The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lunina N.A.

Institute of Molecular Genetics of National Research Centre «Kurchatov Institute»

Safina D.R.

Kazan Federal University

Intercellular interactions in the tumor stroma and their role in oncogenesis

Authors:

Lunina N.A., Safina D.R.

More about the authors

Read: 5322 times


To cite this article:

Lunina NA, Safina DR. Intercellular interactions in the tumor stroma and their role in oncogenesis. Molecular Genetics, Microbiology and Virology. 2022;40(4):3‑8. (In Russ.)
https://doi.org/10.17116/molgen2022400413

Recommended articles:
Primary lymphoma of the central nervous system. Russian Journal of Archive of Pathology. 2025;(6):56-60
Biomarkers of aging mechanisms. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):108-119

References:

  1. Pietras K, Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316(8):1324-1331. https://doi.org/10.1016/j.yexcr.2010.02.045
  2. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423-1437. https://doi.org/10.1038/nm.3394
  3. Vong S, Kalluri R. The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer. 2011;2(12):1139-1145. https://doi.org/10.1177/1947601911423940
  4. Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591-5596. https://doi.org/10.1242/jcs.116392
  5. Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. CancerRes. 2019;79(18):4557-4566. https://doi.org/10.1158/0008-5472.CAN-18-3962
  6. Yuan Y, Jiang YC, Sun CK, Chen QM. Role of the tumor microenvironment in tumor progression and the clinical applications. Oncol Rep. 2016;35(5):2499-2515. https://doi.org/10.3892/or.2016.4660
  7. Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18(12):792-804.  https://doi.org/10.1038/s41571-021-00546-5
  8. Hui L, Chen Y. Tumor Microenvironment: Sanctuary of the Devil. Cancer Lett. 2015;368(1):7-13.  https://doi.org/10.1016/j.canlet.2015.07.039
  9. Gajewski TF, Schreiber H, Fu Y-X. Innate and Adaptive Immune Cells in the Tumor Microenvironment. Nat Immunol. 2013;14(10):1014-1022. https://doi.org/10.1038/ni.2703.
  10. Petty AJ, Yang Y. Tumor-Associated Macrophages: Implications in Cancer Immunotherapy. Immunotherapy. 2017;9(3):289-302.  https://doi.org/10.2217/imt-2016-0135
  11. Zhang D, Zheng Y, Lin Z, Liu X, Li J, Yang H, et.al. Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking for Enhanced Adoptive Immunotherapy in Solid Tumors. Angew Chem Int Ed. 2020;59(29):12022-12028. https://doi.org/10.1002/anie.202002145
  12. Ruscetti M, Morris JP, Mezzadra R, Russell J, Leibold J, Romesser PB, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 2020;181(2):424-441.  https://doi.org/10.1016/j.cell.2020.03.008
  13. Viallard C, Larrivée B. Tumor Angiogenesis and Vascular Normalization: Alternative Therapeutic Targets. Angiogenesis. 2017;20(4):409-426.  https://doi.org/10.1007/s10456-017-9562-9
  14. Eble JA, Niland S. The Extracellular Matrix in Tumor Progression and Metastasis. Clin Exp Metastasis. 2019;36(3):171-198.  https://doi.org/10.1007/s10585-019-09966-1
  15. Girard CA, Lecacheur M, Ben Jouira R, Berestjuk I., Diazzi S, Prod’homme V, et al. A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma. Cancer Res. 2020;80(10):1927-1941. https://doi.org/10.1158/0008-5472.CAN-19-2914
  16. Gerarduzzi C, Hartmann U, Leask A, Drobetsky E. The matrix revolution: matricellular proteins and restructuring of the Cancer microenvironment. Cancer Res. 2020;80(13):2705-2717. https://doi.org/10.1158/0008-5472.CAN-18-2098
  17. Castells M, Thibault B, Delord J-P, Couderc B. Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death. Int J Mol Sci. 2012;13(8):9545-9571. https://doi.org/10.3390/ijms13089545
  18. Kalluri R, Zeisberg M. Fibroblasts in Cancer. Nat Rev Cancer. 2006;6(5):392-401.  https://doi.org/10.1038/nrc1877
  19. Ravikanth M, Manjunath K, Ramachandran CR, Soujanya P, Saraswathi TR. Heterogenecity of fibroblasts. J Oral Maxillofac Pathol. 2011;15(2):247-250.  https://doi.org/10.4103/0973-029X.84516
  20. des Jardins-Park HE, Foster DS, Longaker MT. Fibroblasts and wound healing: an update. Regen Med. 2018;13(5):491-495.  https://doi.org/10.2217/rme-2018-0073
  21. Desmouliere A, Darby IA, Laverdet B, Bont´e F. Fibroblasts and myofibroblasts in wound healing. Clinical, Cosmetic and Investigational Dermatology. 2014;7:301-311.  https://doi.org/10.2147/CCID.S50046
  22. Liu T, Zhou L, Li D, Andl T, Zhang Y. Cancer-associated fibroblasts build and secure the tumor microenvironment. Front Cell Dev Biol. 2019;7:1-14.  https://doi.org/10.3389/fcell.2019.00060
  23. Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A frame work for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174-186.  https://doi.org/10.1038/s41568-019-0238-1
  24. Santi A, Kugeratski FG, Zanivan S. Cancer associated fibroblasts: The architects of stroma remodeling. Proteomics. 2018;18(5-6):e1700167. https://doi.org/10.1002/pmic.201700167
  25. Wang FT, Sun W, Zhang JT, Fan YZ. Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer. Oncol Lett. 2019;17(3):3055-3065. https://doi.org/10.3892/ol.2019.9973
  26. Monteran L, Erez N. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment. Front Immunol. 2019;10:1835. https://doi.org/10.3389/fimmu.2019.01835
  27. Lim H, Moon A. Inflammatory fibroblasts in cancer. Arch Pharm Res. 2016;39(8):1021-1031. https://doi.org/10.1007/s12272-016-0787-8
  28. Labernadie A, Kato T, Brugués A, Serra-Picamal X, Derzsi S, Arwert E, et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol. 2017;19(3):224-237.  https://doi.org/10.1038/ncb3478
  29. Chen W-J, Ho C-C, Chang Y-L, Chen H-Y, Lin C-A, Ling T-Y, et al. Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nat Commun. 2014;5:1-17.  https://doi.org/10.1038/ncomms4472
  30. Nikolopoulou PA, Koufaki MA, Kostourou V. The Adhesome Network: Key Components Shaping the Tumour Stroma. Cancers(Basel). 2021;13(3):525.  https://doi.org/10.3390/cancers13030525
  31. Han L, Lam EW-F, Sun Y. Extracellular vesicles in the tumor microenvironment: old stories, but new tales. Mol Cancer. 2019;18(1):59.  https://doi.org/10.1186/s12943-019-0980-8
  32. Zhang DX, Vu LT, Ismail NN, Le MTN, Grimson A. Landscape of extracellular vesicles in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on metabolic reprogramming, horizjntal transfer of neoplastic traits, and the emergence of therapeutic resistance. Seminars in Cancer Biology. 2021;74:24-44.  https://doi.org/10.1016/j.semcancer.2021.01.007
  33. VanNiel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213-228.  https://doi.org/10.1038/nrm.2017.125
  34. Xie C, Ji N, Tang Z, Li J, Chen Q. The role of extracellular vesicles from different origin in the microenvironment of head and neck cancers. Mol Cancer. 2019;18(1):83.  https://doi.org/10.1186/s12943-019-0985-3
  35. Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. https://doi.org/10.3402/jev.v4.27066
  36. Meldolesi J. Exosomes and ectosomes in intercellular communication. Curr Biol. 2018;28(8):435-444.  https://doi.org/10.1016/j.cub.2018.01.059
  37. Margolis L, Sadovsky Y. The biology of extracellular vesicles: The known unknowns. PLoS Biol. 2019;17(7):e3000363. https://doi.org/10.1371/journal.pbio.3000363
  38. Dai G, Yao X, Zhang Y, Gu J, Geng Y, Xue F, et al. Colorectal cancer cell-derived exosomes containing mir-10b regulate fibroblast cells via the pi3k/akt pathway. Bull Cancer. 2018;105(4):336-349.  https://doi.org/10.1016/j.bulcan.2017.12.009
  39. Walker C, Mojares E, Hernandez ADR. Role of extracellular matrix in development and Cancer progression. Int J Mol Sci. 2018;19(10):3028. https://doi.org/10.3390/ijms19103028
  40. Naito Y, Yamamoto Y, Sakamoto N, Shimomura I, Kogure A, Kumazaki M, et al. Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts. Oncogene. 2019;38(28):5566-5579. https://doi.org/10.1038/s41388-019-0832-4
  41. Hassan MS, Cwidak N, Awasthi N, von Holzen U. Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer. Cancer Control. 2022;29:10732748221078470. https://doi.org/10.1177/10732748221078470
  42. Blank S, Nienhüser H, Dreikhausen L, Sisic L, Heger U, Ott K, et al. Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer. Oncotarget. 2017;8(29):47518-47532. https://doi.org/10.18632/oncotarget.17671
  43. Bhat AA, Nisar S, Maacha S, Carneiro-Lobo TC, Akhtar S, Siveen KS, et al. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. Mol Cancer. 2021;20(1):2.  https://doi.org/10.1186/s12943-020-01294-3
  44. Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. FEBS J. 2018;285(16):2944-2971. https://doi.org/10.1111/febs.144664
  45. Calon A, Tauriello DV, Batlle E. TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer Biol. 2014;25:15-22.  https://doi.org/10.1016/j.semcancer.2013.12.008.
  46. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clinical Investigation. 2009;119(6):1420-1428. https://doi.org/10.1172/JCI39104
  47. Zidi I, Mestiri S, Bartegi A, Amor NB. TNF-alpha and its inhibitors in cancer. Med Oncol. 2010;27(2):185-198.  https://doi.org/10.1007/s12032-009-9190-3
  48. Zhou Q, Wu X, Wang X, Yu Z, Pan T, Li Z, et al. The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis. Oncogene. 2020;39(7):1414-1428. https://doi.org/10.1038/s41388-019-1078-x
  49. Masjedi A, Hashemi V, Hojjat-Farsangi M, Ghalamfarsa G, Azizi G, Yousefi M, et al. The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. Biomed Pharmacother. 2018;108:1415-1424. https://doi.org/10.1016/j.biopha.2018.09.177
  50. Karakasheva TA, Lin EW, Tang Q, Qiao E, Waldron TJ, Soni M, et al. IL-6 Mediates crosstalk between tumor cells and activated fibroblasts in the tumor microenvironment. Cancer Research. 2018;78(17):4957-4970. https://doi.org/10.1158/0008-5472.CAN-17-2268
  51. Baggiolini M. CXCL8 — The First Chemokine. Front Immunol. 2015;6:85.  https://doi.org/10.3389/fimmu.2015.00285
  52. Tong Q, Wang XL, Li SB, Yang G-L, Jin S, Gaoet Z-Y, et al. Combined detection of IL-6 and IL-8 is beneficial to the diagnosis of earlystage esophageal squamous cell cancer: a preliminary study based on the screening of serum markers using protein chips. OncoTargets Ther. 2018;11:5777-5787. https://doi.org/10.2147/OTT.S171242
  53. Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ, et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci USA. 2010;107(24):11026-11031. https://doi.org/10.1073/pnas.0914295107
  54. Moosavi F, Giovannetti E, Saso L, Firuzi O. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers. Crit Rev Clin Lab Sci. 2019;56(8):533-566.  https://doi.org/10.1080/10408363.2019.1653821
  55. Li YY, Tao YW, Gao S, Li P, Zheng JM, Zhang SE, et al. Cancer associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EbioMedicine. 2018;36:209-220.  https://doi.org/10.1016/j.ebiom.2018.09.006
  56. Vu TL, Peng B, Zhang DX, Ma V, Mathey-Andrews CA, Lam CK, et al. Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b. J Extracell. Vesicles. 2019;8(1):1599680. https://doi.org/10.1080/20013078.2019.1599680
  57. Donnarumma E, Fiore D, Nappa M, Roscigno G, Adamo A, Iaboni M, et al. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer. Oncotarget. 2017;8(12):19592-19608. https://doi.org/10.18632/oncotarget.14752
  58. Quinn JJ, Chang H. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2015;17(1):47-62.  https://doi.org/10.1038/nrg.2015.10
  59. del Vecchio F, Lee GH, Hawezi J, Bhome R, Pugh S, Sayan AE, et al. Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk. Cancer Lett. 2018;421:94-102.  https://doi.org/10.1016/j.canlet.2018.02.022
  60. Ahn Y-H, Kim JS. Long Non-Coding RNAs as Regulators of Interactions between Cancer-Associated Fibroblasts and Cancer Cells in the Tumor Microenvironment. Int J Mol Sci. 2020;21(20):7484. https://doi.org/10.3390/ijms21207484

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.